New alternatives for protocols with murine models of asthma [Abstract in English]
Autor(a) principal: | |
---|---|
Data de Publicação: | 2012 |
Outros Autores: | , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | por eng |
Título da fonte: | Scientia Medica (Porto Alegre. Online) |
Texto Completo: | https://revistaseletronicas.pucrs.br/scientiamedica/article/view/10785 |
Resumo: | AIMS: To test alternative protocols using animal models of acute and chronic asthma, with features closer to human disease, using ovalbumin without adjuvant. METHODS: Adult female BALB/c mice were used and divided into groups according to sensitization with ovalbumin. The acute model used two doses of ovalbumin subcutaneously without adjuvant, on days 0 and 7, and after intranasal challenge for consecutives three days, compared with a standard protocol using three doses of ovalbumin for sensitization. The chronic model also used ovalbumin subcutaneously for sensitization, adjuvant-free, on days 0 and 14, and after intranasal challenge, for eight consecutive weeks. Total and differential cell counts from bronchoalveolar lavage and histopathology of the lungs were performed 24 hours after the last ovalbumin challenge. RESULTS: In both models of protocols studied, acute and chronic, we have observed similar allergic pulmonary response between the groups. Cell counts and histological analysis of lung tissue showed no significant difference between groups. CONCLUSIONS: Use of sensitization in murine model with ovalbumin subcutaneously, with no adjuvant (alum), resulted in an expected allergic pulmonary response, with predominant eosinophils. These protocols may be a future option to animal models of asthma closer to the human disease, both in the acute and chronic patterns. |
id |
PUC_RS-25_3c3a1c94459dd2d1b2c7709a8c37fbc6 |
---|---|
oai_identifier_str |
oai:ojs.revistaseletronicas.pucrs.br:article/10785 |
network_acronym_str |
PUC_RS-25 |
network_name_str |
Scientia Medica (Porto Alegre. Online) |
repository_id_str |
|
spelling |
New alternatives for protocols with murine models of asthma [Abstract in English]Novas alternativas para protocolos com modelos murinos de asmaASTHMAALLERGYMICEOVALBUMINANIMALMODELS.ASMAALERGIACAMUNDONGOSOVALBUMINAMODELOS ANIMAIS.AIMS: To test alternative protocols using animal models of acute and chronic asthma, with features closer to human disease, using ovalbumin without adjuvant. METHODS: Adult female BALB/c mice were used and divided into groups according to sensitization with ovalbumin. The acute model used two doses of ovalbumin subcutaneously without adjuvant, on days 0 and 7, and after intranasal challenge for consecutives three days, compared with a standard protocol using three doses of ovalbumin for sensitization. The chronic model also used ovalbumin subcutaneously for sensitization, adjuvant-free, on days 0 and 14, and after intranasal challenge, for eight consecutive weeks. Total and differential cell counts from bronchoalveolar lavage and histopathology of the lungs were performed 24 hours after the last ovalbumin challenge. RESULTS: In both models of protocols studied, acute and chronic, we have observed similar allergic pulmonary response between the groups. Cell counts and histological analysis of lung tissue showed no significant difference between groups. CONCLUSIONS: Use of sensitization in murine model with ovalbumin subcutaneously, with no adjuvant (alum), resulted in an expected allergic pulmonary response, with predominant eosinophils. These protocols may be a future option to animal models of asthma closer to the human disease, both in the acute and chronic patterns.OBJETIVOS: Testar alternativas de protocolos com modelos animais de asma aguda e crônica que apresentem características mais próximas da doença em humanos, utilizando ovalbumina livre de adjuvante. MÉTODOS: Foram utilizadas fêmeas adultas de camundongos BALB/c, divididas em grupos de acordo com as sensibilizações com ovalbumina. O modelo agudo utilizou duas doses de ovalbumina subcutânea, sem adjuvante, com intervalo de sete dias, com posterior desafio intranasal durante três dias, comparado ao protocolo padrão que utiliza três doses de ovalbumina intraperitoneal, no período de sensibilização. O modelo crônico também utilizou ovalbumina subcutânea livre de adjuvante para sensibilização, com intervalo de 14 dias e posterior desafio intranasal, três vezes por semana, durante oito semanas. Contagem total e diferencial de células no lavado broncoalveolar e análise histológica dos pulmões foram realizadas 24 horas após o último desafio com ovalbumina. RESULTADOS: Nos dois modelos estudados, agudo e crônico, observou-se uma resposta eosinofílica pulmonar semelhante entre os grupos. A contagem de células e a análise histológica do tecido pulmonar não apresentaram diferença significativa entre os grupos estudados. CONCLUSÕES: O uso de sensibilização subcutânea em modelo murino com ovalbumina, sem adjuvante (alum), resulta em significativa resposta inflamatória pulmonar alérgica, com predomínio de eosinófilos, podendo ser uma opção futura para experimentos mais próximos ao modelo humano, tanto na fase aguda, como na fase crônica da doença.Editora da PUCRS - ediPUCRS2012-07-27info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdfhttps://revistaseletronicas.pucrs.br/scientiamedica/article/view/10785Scientia Medica; Vol. 22 No. 2 (2012); 71-80Scientia Medica; v. 22 n. 2 (2012); 71-801980-61081806-5562reponame:Scientia Medica (Porto Alegre. Online)instname:Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)instacron:PUC_RSporenghttps://revistaseletronicas.pucrs.br/scientiamedica/article/view/10785/8153https://revistaseletronicas.pucrs.br/scientiamedica/article/view/10785/8154Parreira, CamilaRodrigues, Andrea MendonçaGualdi, Lucien PeroniCao, Raquel Giacomellide Souza, Rodrigo GodinhoPereira, Ana CláudiaNuñez, Nailê KarineSchleich, AlissonVargas, Mauro HenriquePitrez, Paulo Márcioinfo:eu-repo/semantics/openAccess2013-07-15T18:44:36Zoai:ojs.revistaseletronicas.pucrs.br:article/10785Revistahttps://revistaseletronicas.pucrs.br/scientiamedica/PUBhttps://revistaseletronicas.pucrs.br/scientiamedica/oaiscientiamedica@pucrs.br || editora.periodicos@pucrs.br1980-61081806-5562opendoar:2013-07-15T18:44:36Scientia Medica (Porto Alegre. Online) - Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)false |
dc.title.none.fl_str_mv |
New alternatives for protocols with murine models of asthma [Abstract in English] Novas alternativas para protocolos com modelos murinos de asma |
title |
New alternatives for protocols with murine models of asthma [Abstract in English] |
spellingShingle |
New alternatives for protocols with murine models of asthma [Abstract in English] Parreira, Camila ASTHMA ALLERGY MICE OVALBUMIN ANIMAL MODELS. ASMA ALERGIA CAMUNDONGOS OVALBUMINA MODELOS ANIMAIS. |
title_short |
New alternatives for protocols with murine models of asthma [Abstract in English] |
title_full |
New alternatives for protocols with murine models of asthma [Abstract in English] |
title_fullStr |
New alternatives for protocols with murine models of asthma [Abstract in English] |
title_full_unstemmed |
New alternatives for protocols with murine models of asthma [Abstract in English] |
title_sort |
New alternatives for protocols with murine models of asthma [Abstract in English] |
author |
Parreira, Camila |
author_facet |
Parreira, Camila Rodrigues, Andrea Mendonça Gualdi, Lucien Peroni Cao, Raquel Giacomelli de Souza, Rodrigo Godinho Pereira, Ana Cláudia Nuñez, Nailê Karine Schleich, Alisson Vargas, Mauro Henrique Pitrez, Paulo Márcio |
author_role |
author |
author2 |
Rodrigues, Andrea Mendonça Gualdi, Lucien Peroni Cao, Raquel Giacomelli de Souza, Rodrigo Godinho Pereira, Ana Cláudia Nuñez, Nailê Karine Schleich, Alisson Vargas, Mauro Henrique Pitrez, Paulo Márcio |
author2_role |
author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Parreira, Camila Rodrigues, Andrea Mendonça Gualdi, Lucien Peroni Cao, Raquel Giacomelli de Souza, Rodrigo Godinho Pereira, Ana Cláudia Nuñez, Nailê Karine Schleich, Alisson Vargas, Mauro Henrique Pitrez, Paulo Márcio |
dc.subject.por.fl_str_mv |
ASTHMA ALLERGY MICE OVALBUMIN ANIMAL MODELS. ASMA ALERGIA CAMUNDONGOS OVALBUMINA MODELOS ANIMAIS. |
topic |
ASTHMA ALLERGY MICE OVALBUMIN ANIMAL MODELS. ASMA ALERGIA CAMUNDONGOS OVALBUMINA MODELOS ANIMAIS. |
description |
AIMS: To test alternative protocols using animal models of acute and chronic asthma, with features closer to human disease, using ovalbumin without adjuvant. METHODS: Adult female BALB/c mice were used and divided into groups according to sensitization with ovalbumin. The acute model used two doses of ovalbumin subcutaneously without adjuvant, on days 0 and 7, and after intranasal challenge for consecutives three days, compared with a standard protocol using three doses of ovalbumin for sensitization. The chronic model also used ovalbumin subcutaneously for sensitization, adjuvant-free, on days 0 and 14, and after intranasal challenge, for eight consecutive weeks. Total and differential cell counts from bronchoalveolar lavage and histopathology of the lungs were performed 24 hours after the last ovalbumin challenge. RESULTS: In both models of protocols studied, acute and chronic, we have observed similar allergic pulmonary response between the groups. Cell counts and histological analysis of lung tissue showed no significant difference between groups. CONCLUSIONS: Use of sensitization in murine model with ovalbumin subcutaneously, with no adjuvant (alum), resulted in an expected allergic pulmonary response, with predominant eosinophils. These protocols may be a future option to animal models of asthma closer to the human disease, both in the acute and chronic patterns. |
publishDate |
2012 |
dc.date.none.fl_str_mv |
2012-07-27 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://revistaseletronicas.pucrs.br/scientiamedica/article/view/10785 |
url |
https://revistaseletronicas.pucrs.br/scientiamedica/article/view/10785 |
dc.language.iso.fl_str_mv |
por eng |
language |
por eng |
dc.relation.none.fl_str_mv |
https://revistaseletronicas.pucrs.br/scientiamedica/article/view/10785/8153 https://revistaseletronicas.pucrs.br/scientiamedica/article/view/10785/8154 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Editora da PUCRS - ediPUCRS |
publisher.none.fl_str_mv |
Editora da PUCRS - ediPUCRS |
dc.source.none.fl_str_mv |
Scientia Medica; Vol. 22 No. 2 (2012); 71-80 Scientia Medica; v. 22 n. 2 (2012); 71-80 1980-6108 1806-5562 reponame:Scientia Medica (Porto Alegre. Online) instname:Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS) instacron:PUC_RS |
instname_str |
Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS) |
instacron_str |
PUC_RS |
institution |
PUC_RS |
reponame_str |
Scientia Medica (Porto Alegre. Online) |
collection |
Scientia Medica (Porto Alegre. Online) |
repository.name.fl_str_mv |
Scientia Medica (Porto Alegre. Online) - Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS) |
repository.mail.fl_str_mv |
scientiamedica@pucrs.br || editora.periodicos@pucrs.br |
_version_ |
1809101749625028608 |